Kineta, Inc. has entered into a merger agreement to be acquired by TuHURA Biosciences, Inc.

Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.

Crossbeam and Revel have merged to create "a best-of-both-worlds customer experience that includes a single unified data network."

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.

Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.

Jasper, “an AI copilot for marketing teams,” has acquired Paris-based Clipdrop from Stability AI.

Doppel, the AI-native digital risk protection company, has raised $14 million in a Series A funding round.